Brief: Clariane Lowers 2025 Full Year EBITDA Target
Oct 27 (Reuters) - Clariane SE CLARI.PA: SALES AT 30 SEPTEMBER 2025 WERE €3,976M ORGANIC SALES GROWTH TARGET CONFIRMED EBITDA, PRE-IFRS 16 AND PRO FORMA FOR DISPOSALS FOR THE FULL YEAR IS EXPECTED TO INCREASE, ALTHOUGH AT A LEVEL BELOW THE INITIAL RANGE OF +6% TO +9% Source text: https://tinyurl.com/bvr4f8dd Further company coverage: CLARI.PA (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Clariane SE
See all newsFrench and Benelux stocks-Factors to watch
Brief: Clariane To Issue €333 Million Of Hybrid Notes
Brief: Clariane Has Launched A Proposed Offering Of €333 Million Of Undated Deeply Subordinated Hybrid Notes To Refinance Its Odirnane
Europe Research Roundup: Basic-Fit, ENI, Nexans
Brief: Clariane Announces The Success Of Its Offering Of €230 Million Of Additional Senior Notes